In hepatocellular carcinoma (HCC) and glioblastoma multiforme (GBM), abnormal expression of BMAL1 is significantly correlated with enhanced tumor cell proliferation capacity, increased invasive potential, and heightened migratory activity [17]. Here, BMAL1 is linked to hepatocellular carcinoma.